{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:18:15Z","timestamp":1793596695601,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s13304-019-00670-z","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T12:02:46Z","timestamp":1561723366000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery"],"prefix":"10.1007","volume":"71","author":[{"given":"Leonid","family":"Cherkassky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"670_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"TA Aloia","year":"2015","unstructured":"Aloia TA, Jarufe N, Javle M et al (2015) Gallbladder cancer: expert consensus statement. HPB (Oxford) 17:681\u2013690","journal-title":"HPB (Oxford)"},{"key":"670_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1477-2574.2011.00325.x","volume":"13","author":"JM Butte","year":"2011","unstructured":"Butte JM, Gonen M, Allen PJ et al (2011) The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 13:463\u2013472","journal-title":"HPB (Oxford)"},{"key":"670_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1245\/s10434-008-0189-3","volume":"16","author":"M D\u2019Angelica","year":"2009","unstructured":"D\u2019Angelica M, Dalal KM, DeMatteo RP et al (2009) Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 16:806\u2013816","journal-title":"Ann Surg Oncol"},{"key":"670_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00000658-199611000-00008","volume":"224","author":"DL Bartlett","year":"1996","unstructured":"Bartlett DL, Fong Y, Fortner JG et al (1996) Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 224:639\u2013646","journal-title":"Ann Surg"},{"key":"670_CR5","first-page":"419","volume":"163","author":"XA de Aretxabala","year":"1997","unstructured":"de Aretxabala XA, Roa IS, Burgos LA et al (1997) Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 163:419\u2013426","journal-title":"Eur J Surg"},{"key":"670_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0002-9610(92)90109-5","volume":"163","author":"Y Matsumoto","year":"1992","unstructured":"Matsumoto Y, Fujii H, Aoyama H et al (1992) Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 163:239\u2013245","journal-title":"Am J Surg"},{"key":"670_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/00000658-199211000-00007","volume":"216","author":"Y Shirai","year":"1992","unstructured":"Shirai Y, Yoshida K, Tsukada K et al (1992) Radical surgery for gallbladder carcinoma. Long-term results. Ann Surg 216:565\u2013568","journal-title":"Ann Surg"},{"key":"670_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00000658-200010000-00011","volume":"232","author":"Y Fong","year":"2000","unstructured":"Fong Y, Jarnagin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232:557\u2013569","journal-title":"Ann Surg"},{"key":"670_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1245\/s10434-006-9097-6","volume":"14","author":"JM Foster","year":"2007","unstructured":"Foster JM, Hoshi H, Gibbs JF et al (2007) Gallbladder cancer: defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 14:833\u2013840","journal-title":"Ann Surg Oncol"},{"key":"670_CR10","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1007\/s00464-010-0914-4","volume":"24","author":"TO Goetze","year":"2010","unstructured":"Goetze TO, Paolucci V (2010) Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc 24:2156\u20132164","journal-title":"Surg Endosc"},{"key":"670_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s005340200028","volume":"9","author":"K Ouchi","year":"2002","unstructured":"Ouchi K, Mikuni J, Kakugawa Y et al (2002) Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg 9:256\u2013260","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"670_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00000658-199204000-00004","volume":"215","author":"Y Shirai","year":"1992","unstructured":"Shirai Y, Yoshida K, Tsukada K et al (1992) Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215:326\u2013331","journal-title":"Ann Surg"},{"key":"670_CR13","first-page":"1316","volume":"325","author":"F Drouard","year":"1991","unstructured":"Drouard F, Delamarre J, Capron JP (1991) Cutaneous seeding of gallbladder cancer after laparoscopic cholecystectomy. N Engl J Med 325:1316","journal-title":"N Engl J Med"},{"key":"670_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/archsurg.1993.01420210118016","volume":"128","author":"Y Fong","year":"1993","unstructured":"Fong Y, Brennan MF, Turnbull A et al (1993) Gallbladder cancer discovered during laparoscopic surgery Potential for iatrogenic tumor dissemination. Arch Surg 128:1054\u20131056","journal-title":"Arch Surg"},{"key":"670_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/SLA.0b013e31806beec2","volume":"245","author":"SP Shih","year":"2007","unstructured":"Shih SP, Schulick RD, Cameron JL et al (2007) Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 245:893\u2013901","journal-title":"Ann Surg"},{"key":"670_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","volume":"241","author":"E Dixon","year":"2005","unstructured":"Dixon E, Vollmer CM Jr, Sahajpal A et al (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241:385\u2013394","journal-title":"Ann Surg"},{"key":"670_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1072-7515(01)00814-6","volume":"192","author":"K Chijiiwa","year":"2001","unstructured":"Chijiiwa K, Nakano K, Ueda J et al (2001) Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg 192:600\u2013607","journal-title":"J Am Coll Surg"},{"key":"670_CR18","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00268-011-1134-3","volume":"35","author":"D Fuks","year":"2011","unstructured":"Fuks D, Regimbeau JM, Le Treut YP et al (2011) Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg 35:1887\u20131897","journal-title":"World J Surg"},{"key":"670_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey JN (2018) 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol 25:845\u2013847","journal-title":"Ann Surg Oncol"},{"key":"670_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1477-2574.2012.00559.x","volume":"15","author":"DM Hari","year":"2013","unstructured":"Hari DM, Howard JH, Leung AM et al (2013) A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford) 15:40\u201348","journal-title":"HPB (Oxford)"},{"key":"670_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.01.069","volume":"219","author":"JM Butte","year":"2014","unstructured":"Butte JM, Kingham TP, Gonen M et al (2014) Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg 219:416\u2013429","journal-title":"J Am Coll Surg"},{"key":"670_CR22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jso.21681","volume":"102","author":"JM Butte","year":"2010","unstructured":"Butte JM, Waugh E, Meneses M et al (2010) Incidental gallbladder cancer: analysis of surgical findings and survival. J Surg Oncol 102:620\u2013625","journal-title":"J Surg Oncol"},{"key":"670_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/hpb.12282","volume":"16","author":"U Leung","year":"2014","unstructured":"Leung U, Pandit-Taskar N, Corvera CU et al (2014) Impact of pre-operative positron emission tomography in gallbladder cancer. HPB (Oxford) 16:1023\u20131030","journal-title":"HPB (Oxford)"},{"key":"670_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD et al (2008) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26:778\u2013785","journal-title":"J Clin Oncol"},{"key":"670_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx302.007","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Pauligk C, Homann N et al (2017) LBA-008Docetaxel, oxaliplatin, and fluorouracil\/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF\/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: the multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO). Ann Oncol. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdx302.007","journal-title":"Ann Oncol"},{"key":"670_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11\u201320","journal-title":"N Engl J Med"},{"key":"670_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1245\/s10434-011-1900-3","volume":"19","author":"JM Winter","year":"2012","unstructured":"Winter JM, Brennan MF, Tang LH et al (2012) Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol 19:169\u2013175","journal-title":"Ann Surg Oncol"},{"key":"670_CR28","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M et al (2018) FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379:2395\u20132406","journal-title":"N Engl J Med"},{"key":"670_CR29","doi-asserted-by":"publisher","first-page":"e161137","DOI":"10.1001\/jamasurg.2016.1137","volume":"151","author":"MH Katz","year":"2016","unstructured":"Katz MH, Shi Q, Ahmad SA et al (2016) Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial a021101. JAMA Surg 151:e161137","journal-title":"JAMA Surg"},{"key":"670_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","volume":"4","author":"JE Murphy","year":"2018","unstructured":"Murphy JE, Wo JY, Ryan DP et al (2018) Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial. JAMA Oncol 4:963\u2013969","journal-title":"JAMA Oncol"},{"key":"670_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.surg.2015.09.018","volume":"159","author":"KK Christians","year":"2016","unstructured":"Christians KK, Heimler JW, George B et al (2016) Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery 159:893\u2013900","journal-title":"Surgery"},{"key":"670_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/hpb.12032","volume":"15","author":"F Ausania","year":"2013","unstructured":"Ausania F, Tsirlis T, White SA et al (2013) Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3\u00a0months prior to a radical resection. HPB (Oxford) 15:633\u2013637","journal-title":"HPB (Oxford)"},{"key":"670_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273\u20131281","journal-title":"N Engl J Med"},{"key":"670_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","volume":"254","author":"H Ito","year":"2011","unstructured":"Ito H, Ito K, D\u2019Angelica M et al (2011) Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 254:320\u2013325","journal-title":"Ann Surg"},{"key":"670_CR35","first-page":"452","volume":"6","author":"TB Tran","year":"2015","unstructured":"Tran TB, Nissen NN (2015) Surgery for gallbladder cancer in the US: a need for greater lymph node clearance. J Gastrointest Oncol 6:452\u2013458","journal-title":"J Gastrointest Oncol"},{"key":"670_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","volume":"261","author":"J Shindoh","year":"2015","unstructured":"Shindoh J, de Aretxabala X, Aloia TA et al (2015) Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg 261:733\u2013739","journal-title":"Ann Surg"},{"key":"670_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003325","author":"MJ Horkoff","year":"2019","unstructured":"Horkoff MJ, Ahmed Z, Xu Y et al (2019) Adverse outcomes after bile spillage in incidental gallbladder cancers: a population-based study. Ann Surg. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000003325","journal-title":"Ann Surg"},{"key":"670_CR38","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.3748\/wjg.v13.i33.4480","volume":"13","author":"M Nagahashi","year":"2007","unstructured":"Nagahashi M, Shirai Y, Wakai T et al (2007) Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders. World J Gastroenterol 13:4480\u20134483","journal-title":"World J Gastroenterol"},{"key":"670_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00000658-196207000-00021","volume":"156","author":"RB Fahim","year":"1962","unstructured":"Fahim RB, Mc DJ, Richards JC et al (1962) Carcinoma of the gallbladder: a study of its modes of spread. Ann Surg 156:114\u2013124","journal-title":"Ann Surg"},{"key":"670_CR40","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","volume":"224","author":"JM Creasy","year":"2017","unstructured":"Creasy JM, Goldman DA, Dudeja V et al (2017) Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg 224:906\u2013916","journal-title":"J Am Coll Surg"},{"key":"670_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20:663\u2013673","journal-title":"Lancet Oncol"},{"key":"670_CR42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.18.00050","volume":"37","author":"J Edeline","year":"2019","unstructured":"Edeline J, Benabdelghani M, Bertaut A et al (2019) Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol 37:658\u2013667","journal-title":"J Clin Oncol"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-019-00670-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13304-019-00670-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-019-00670-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T02:42:18Z","timestamp":1593225738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13304-019-00670-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s13304-019-00670-z","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not involve research on human subjects or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"This manuscript was a review of the literature pertaining to gallbladder cancer. Therefore, there are no issues pertaining to informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}